Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Rapid Micro Biosystems announced its participation in the 41^st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 9:45 AM PT (12:45 PM ET). The company will discuss its innovative automation solutions for healthcare manufacturing. A live webcast will be accessible on the Rapid Micro Biosystems investor relations website and archived for 30 days post-event. Headquartered in Lowell, Massachusetts, the company focuses on modernizing microbial quality control testing in the pharmaceutical industry.

LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 41^st Annual J.P. Morgan Healthcare Conference.

The Company is scheduled to present on Thursday, January 12, 2023 at 9:45am Pacific Time (12:45pm Eastern Time). A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay for at least 30 days after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making, that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Lexington, Massachusetts, Switzerland, Germany, and the Netherlands.

For more information, please visit www.rapidmicrobio.com or follow the Company on Twitter at @rapidmicrobio or on LinkedIn.

FAQ

What is the date of Rapid Micro Biosystems' presentation at the J.P. Morgan Healthcare Conference?

Rapid Micro Biosystems will present on January 12, 2023.

What time is Rapid Micro Biosystems presenting at the conference?

The presentation is scheduled for 9:45 AM Pacific Time.

Where can I watch the Rapid Micro Biosystems presentation live?

The webcast can be accessed on the Rapid Micro Biosystems investor relations website.

How long will the webcast of the Rapid Micro Biosystems presentation be available?

The webcast will be archived for at least 30 days after the event.

What is the focus of Rapid Micro Biosystems' technology?

The company provides automation solutions for microbial quality control in healthcare manufacturing.